DR. DANIEL COSTA of Beth Israel Deaconess Medical Center (a teaching hospital of Harvard Medical School) has been selected to receive the 2012 LCFA/IASLC Grant in Translational Lung Cancer Research. Dr. Costa will receive the $300,000.00 two-year grant, to study Non-Small Cell Lung Cancer (NSCLC) patients with different EGFR mutations. Dr. Costa and his team intend to evaluate these selected patients for sensitivity and resistance to EGFR tyrosine kinase inhibitors (TKIs) to determine a genotype-response correlation.

Dr. Costa, a native of Brazil, received his MD from …
Read More

DR. JESSICA DONINGTON was selected from more than a dozen international applicants to receive one of LCFA’s first scientific research grants. In partnership with the International Association for the Study of Lung Cancer (IASLC), the LCFA Lung Cancer Research Grant awarded a 2-year $250,000 grant to Dr. Donington at New York University (NYU) for her research.

Dr .Donington, a native New Yorker trained at…
Read More

DR. GOEFFREY LIU was also selected from more than a dozen international applicants to receive the second of LCFA’s initial scientific research grants. In partnership with the International Association for the Study of Lung Cancer (IASLC), the LCFA Lung Cancer Research Grant awarded $39,000 to Dr. Goeffrey Liu for his study of the genetic differences in patients treated with anti-angiogenic agents. Dr Liu’s research endeavored to see if he could identify which patients benefit…
Read More